L Patrick Gage's Net Worth
$2.98 Million
Who is L Patrick Gage?
L Patrick Gage has an estimated net worth of $2.98 Million. This is based on reported shares across multiple companies, which include TETRAPHASE PHARMACEUTICALS INC, CYTOKINETICS INC, PDL BIOPHARMA, INC., and NEOSE TECHNOLOGIES INC.
SEC CIK
L Patrick Gage's CIK is 0001196903
Past Insider Trading and Trends
2015 was L Patrick Gage's most active year for acquiring shares with 19 total transactions. L Patrick Gage's most active month to acquire stocks was the month of April. 2017 was L Patrick Gage's most active year for disposing of shares, totalling 18 transactions. L Patrick Gage's most active month to dispose stocks was the month of August. 2020 saw L Patrick Gage paying a total of $588,393.74 for 31,049 shares, this is the most they've acquired in one year. In 2021 L Patrick Gage cashed out on 93,614 shares for a total of $1,557,862.89, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRAPHASE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.13K |
—
|
—
|
0
|
Jul 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
| +11.09% | 3.88K |
$6.45 | $25,026.00 | 38.88K |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +39.53% | 11K |
$7.48 | $82,370.00 | 38.83K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +400.00% | 20K |
$2.03 | $40,600.00 | 25K |
Oct 2
| |||
Form 4
|
—
|
0
|
$26.04 | -$568,950.00 | 5K |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +21.51% | 500 |
$11.42 | $5,710.00 | 2.83K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +72.22% | 975 |
$10.28 | $10,026.90 | 2.33K |
Jun 5
| |||
Form 4
| +58.82% | 500 |
$10.05 | $5,025.00 | 1.35K |
Jun 4
| |||
Form 4
|
∞
| 850 |
$10.70 | $9,095.00 | 850 |
May 28
| |||
Form 4
|
∞
| 5K |
$9.25 | $46,249.00 | 5K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CYTOKINETICS INC (CYTK) Snapshot price: $54.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$22.79 | -$981,622.62 | 28.93K |
Nov 8
| |||
Form 4
| +1.79% | 510 |
$36.74 | $18,737.40 | 28.93K |
Oct 1
| |||
Form 4
| +3.24% | 893 |
$20.98 | $18,735.14 | 28.42K |
Jul 1
| |||
Form 4
| +22.19% | 5K |
—
|
—
| 27.53K |
May 12
| |||
Form 4
| +3.52% | 767 |
$24.44 | $18,745.48 | 22.53K |
Apr 1
| |||
Form 4
|
—
|
0
|
$15.17 | -$185,668.00 | 21.76K |
Mar 19
| |||
Form 4
|
—
|
0
|
$14.00 | -$149,379.47 | 21.76K |
Mar 12
| |||
Form 4
| +4.60% | 958 |
$19.56 | $18,738.48 | 21.76K |
Jan 4
| |||
Form 4
|
—
|
0
|
$16.98 | -$62,038.95 | 20.8K |
Dec 15
| |||
Form 4
| +4.02% | 804 |
$19.54 |
—
| 20.8K |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
| -28.57% | -8.00K |
$14.82 | -$118,592.00 | 20K |
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$9.31 | -$52,844.00 | 30K |
Scheduled
|
Oct 2
| ||
Form 4
|
—
|
0
|
$9.37 | -$53,522.50 | 30K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$9.01 | -$49,900.00 | 30K |
Scheduled
|
Aug 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +117.65% | 1K |
$6.95 | $6,950.00 | 1.85K |
Aug 31
| |||
Form 4
| +50.00% | 10K |
$6.55 | $65,489.45 | 30K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +100.00% | 10K |
$5.71 | $57,123.78 | 20K |
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
∞
| 10.85K |
$4.10 | $44,377.00 | 10.85K |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PDL BIOPHARMA, INC. No price found
Interim CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +158.84% | 12K |
$7.01 | $84,120.00 | 19.55K |
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +277.75% | 5.55K |
$18.05 | $100,242.20 | 7.55K |
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
∞
| 2K |
$19.04 | $38,078.00 | 2K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 24
| |||
No matching records found |
NEOSE TECHNOLOGIES INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.20% | 8.2K |
—
|
—
| 75.4K |
Jan 27
| |||
Form 4
| +142.60% | 39.5K |
$2.60 | $102,561.00 | 67.2K |
Jun 7 - Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +118.11% | 15K |
$2.02 | $30,336.00 | 27.7K |
Mar 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +262.86% | 9.2K |
$2.78 | $25,573.00 | 12.7K |
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |